Cargando…

Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer

Inter- and intra-fractional prostate motion can deteriorate the dose distribution in extremely hypofractionated intensity-modulated proton therapy. We used verification CTs and prostate motion data calculated from 1024 intra-fractional prostate motion records to develop a voxel-wise based 4-dimensio...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Sen-Quan, Brouwer, Charlotte L., Korevaar, Erik W., Vapiwala, Neha, Kang-Hsin Wang, Ken, Deville, Curtiland, Langendijk, Johannes A., Both, Stefan, Aluwini, Shafak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407426/
https://www.ncbi.nlm.nih.gov/pubmed/37560512
http://dx.doi.org/10.1016/j.phro.2023.100474
_version_ 1785085959203717120
author Feng, Sen-Quan
Brouwer, Charlotte L.
Korevaar, Erik W.
Vapiwala, Neha
Kang-Hsin Wang, Ken
Deville, Curtiland
Langendijk, Johannes A.
Both, Stefan
Aluwini, Shafak
author_facet Feng, Sen-Quan
Brouwer, Charlotte L.
Korevaar, Erik W.
Vapiwala, Neha
Kang-Hsin Wang, Ken
Deville, Curtiland
Langendijk, Johannes A.
Both, Stefan
Aluwini, Shafak
author_sort Feng, Sen-Quan
collection PubMed
description Inter- and intra-fractional prostate motion can deteriorate the dose distribution in extremely hypofractionated intensity-modulated proton therapy. We used verification CTs and prostate motion data calculated from 1024 intra-fractional prostate motion records to develop a voxel-wise based 4-dimensional method, which had a time resolution of 1 s, to assess the dose impact of prostate motion. An example of 100 fractional simulations revealed that motion had minimal impact on planning dose, the accumulated dose in 95 % of the scenarios fulfilled the clinical goals for target coverage (D95 > 37.5 Gy). This method can serve as a complementary measure in clinical setting to guarantee plan quality.
format Online
Article
Text
id pubmed-10407426
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104074262023-08-09 Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer Feng, Sen-Quan Brouwer, Charlotte L. Korevaar, Erik W. Vapiwala, Neha Kang-Hsin Wang, Ken Deville, Curtiland Langendijk, Johannes A. Both, Stefan Aluwini, Shafak Phys Imaging Radiat Oncol Technical Note Inter- and intra-fractional prostate motion can deteriorate the dose distribution in extremely hypofractionated intensity-modulated proton therapy. We used verification CTs and prostate motion data calculated from 1024 intra-fractional prostate motion records to develop a voxel-wise based 4-dimensional method, which had a time resolution of 1 s, to assess the dose impact of prostate motion. An example of 100 fractional simulations revealed that motion had minimal impact on planning dose, the accumulated dose in 95 % of the scenarios fulfilled the clinical goals for target coverage (D95 > 37.5 Gy). This method can serve as a complementary measure in clinical setting to guarantee plan quality. Elsevier 2023-07-22 /pmc/articles/PMC10407426/ /pubmed/37560512 http://dx.doi.org/10.1016/j.phro.2023.100474 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Technical Note
Feng, Sen-Quan
Brouwer, Charlotte L.
Korevaar, Erik W.
Vapiwala, Neha
Kang-Hsin Wang, Ken
Deville, Curtiland
Langendijk, Johannes A.
Both, Stefan
Aluwini, Shafak
Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer
title Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer
title_full Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer
title_fullStr Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer
title_full_unstemmed Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer
title_short Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer
title_sort dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer
topic Technical Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407426/
https://www.ncbi.nlm.nih.gov/pubmed/37560512
http://dx.doi.org/10.1016/j.phro.2023.100474
work_keys_str_mv AT fengsenquan doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer
AT brouwercharlottel doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer
AT korevaarerikw doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer
AT vapiwalaneha doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer
AT kanghsinwangken doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer
AT devillecurtiland doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer
AT langendijkjohannesa doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer
AT bothstefan doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer
AT aluwinishafak doseevaluationofinterandintrafractionprostatemotioninextremelyhypofractionatedintensitymodulatedprotontherapyforprostatecancer